You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 9, September 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Study
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (11)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Dermatologic Disorders
 •Acne
 •Pulmonary Diseases
 •Pulmonary Diseases, Other
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Antibiotic Treatment of Acne May Be Associated With Upper Respiratory Tract Infections

David J. Margolis, MD, PhD; Whitney P. Bowe, BS; Ole Hoffstad, MA; Jesse A. Berlin, ScD

Arch Dermatol. 2005;141:1132-1136.

Objective  To determine if the long-term use of antibiotics for the treatment of acne results in an increase in either of 2 common infectious illnesses: upper respiratory tract infections (URTIs) or urinary tract infections.

Design  Retrospective cohort study.

Setting  General Practice Research Database of the United Kingdom, London, England, from 1987 to 2002.

Patients  Patients with a diagnosis of acne.

Main Outcome Measure  The onset of either a URTI or a urinary tract infection.

Results  Of 118 496 individuals with acne (age range, 15-35 years) who were identified in the General Practice Research Database, 84 977 (71.7%) received a topical or oral antibiotic (tetracyclines, erythromycin, or clindamycin) for treatment of their acne and 33 519 (28.3%) did not. Within the first year of observation, 18 281 (15.4%) of the patients with acne had at least 1 URTI, and within that year, the odds of a URTI developing among those receiving antibiotic treatment were 2.15 (95% confidence interval, 2.05-2.23; P<.001) times greater than among those who were not receiving antibiotic treatment. Multiple additional analyses, which were conducted to show that this effect was not an artifact of increased health care–seeking behavior among our cohorts, included comparing the cohorts of patients with acne with a cohort of patients with hypertension and the likelihood of developing a urinary tract infection.

Conclusions  Patients with acne who were receiving antibiotic treatment for acne were more likely to develop a URTI than those with acne who were not receiving such treatment. The true clinical importance of our findings will require further investigation.


Author Affiliations: Departments of Dermatology (Dr Margolis and Ms Bowe) and Biostatistics and Epidemiology (Drs Margolis and Berlin and Mr Hoffstad), University of Pennsylvania Center for Education and Research in Therapeutics, Philadelphia. Dr Berlin is now with Johnson & Johnson Pharmaceutical Research and Development, La Jolla, Calif.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Acne, Antibiotics, and Upper Respiratory Tract Infections
An-Wen Chan and James C. Shaw
Arch Dermatol. 2005;141(9):1157-1158.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Skin Microecology: The Old and the New
Webster
Arch Dermatol 2007;143:105-106.
FULL TEXT  

Acne maintenance therapy: expanding the role of topical retinoids?
Zane
Arch Dermatol 2006;142:638-640.
FULL TEXT  

Acne Antibiotics Increase Risk for Upper Respiratory Tract Infections
Journal Watch Dermatology 2005;2005:2-2.
FULL TEXT  

Acne, Antibiotics, and Upper Respiratory Tract Infections
Chan and Shaw
Arch Dermatol 2005;141:1157-1158.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.